دورية أكاديمية
Determining the Minimal Clinically Important Difference (MCID) and Responsiveness of the Chinese Version of Zurich Chronic Middle Ear Inventory (ZCMEI-21-Chn): A Prospective Multicenter Study.
| العنوان: | Determining the Minimal Clinically Important Difference (MCID) and Responsiveness of the Chinese Version of Zurich Chronic Middle Ear Inventory (ZCMEI-21-Chn): A Prospective Multicenter Study. |
|---|---|
| المؤلفون: | Yang R; Department of Otorhinolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang Y; Department of Diseases Prevention and Control, Peking University Third Hospital, Beijing, China., Feng G; Department of Otorhinolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Han W; Department of Otorhinolaryngology Head and Neck Surgery, Chinese People's Liberation Army General Hospital, Beijing, China., Li Y; Department of Otorhinolaryngology, Tongren Hospital, Capital Medical University, Beijing, PR China., Li S; Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, PR China., Pan T; Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, PR China., Ke J; Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, PR China., Zhang K; Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, PR China., Xin Y; Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, PR China., Song Y; Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, PR China., Zuo Q; Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, PR China., Zhao Y; Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, PR China., Zhou N; Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, PR China., Yao Z; Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, PR China., Röösli C; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Huber AM; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Bächinger D; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Ma F; Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, PR China., Gao Z; Department of Otorhinolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. |
| المصدر: | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology [Otol Neurotol] 2024 Aug 01; Vol. 45 (7), pp. e532-e540. Date of Electronic Publication: 2024 Jul 02. |
| نوع المنشور: | Journal Article; Multicenter Study |
| اللغة: | English |
| بيانات الدورية: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100961504 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-4505 (Electronic) Linking ISSN: 15317129 NLM ISO Abbreviation: Otol Neurotol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Hagerstown, MD : Lippincott Williams & Wilkins, c2001- |
| مواضيع طبية MeSH: | Quality of Life* , Minimal Clinically Important Difference* , Otitis Media*/surgery, Humans ; Male ; Female ; Middle Aged ; Adult ; Prospective Studies ; Chronic Disease ; Surveys and Questionnaires/standards ; Tympanoplasty/methods ; Aged ; China ; Reproducibility of Results ; Treatment Outcome |
| مستخلص: | Objectives: This study aimed to establish the minimal clinically important difference (MCID) and assess the responsiveness of the Chinese version of Zurich Chronic Middle Ear Inventory (ZCMEI-21-Chn). Study Design: Prospective multicenter study. Setting: Four Chinese tertiary referral centers admitting patients nationwide. Patients: 230 adult patients with chronic otitis media (COM) undergoing tympanoplasty. Intervention: Patients were required to complete the ZCMEI-21-Chn to measure health-related quality of life both preoperatively and postoperatively. An anchor-based method was used to determine the MCID of the derivative cohort by including the Global Rating of Change Questionnaire as an anchor. The generalizability and consistency with functional outcomes of the MCID estimates were externally examined in a validation cohort using a receiver operating characteristic curve analysis. Results: A total of 161 and 69 patients were included in the derivative and validation cohort. The mean preoperative and postoperative ZCMEI-21-Chn total scores were 28.4 (standard deviation [SD] 14.5) and 17.5 (SD 12.6). The mean change in ZCMEI-21-Chn score was 10.9 (SD 14.3, p < 0.001). The MCIDs of the ZCMEI-21-Chn for improvement and deterioration were estimated at 13 (SD 13.0) and -7 (SD 12.9), accordingly. For patients who have reported an improved health-related quality of life, a cutoff value of 15.6 dB HL for elevation of the air-conducted hearing threshold was noticed. However, change of clinical importance judged according to MCID and Japan Otological Society criteria disagreed with each other, notably with a Cohen's kappa ( κ ) of 0.14 ( p = 0.21) in the validation cohort. Conclusion: This study is the first to establish the MCID of a COM-specific questionnaire in Chinese. For the COM population undergoing surgical intervention, MCID values of 13 for improvement and -7 for deterioration are recommended. The results were externally validated to be generalizable to nationwide usage, yet distinguishable from the audiological criteria. The availability of the MCID greatly adds to the clinical utility of the ZCMEI-21-Chn by enabling a clinically meaningful interpretation of its score changes. Competing Interests: The authors disclose no conflicts of interest. (Copyright © 2024, Otology & Neurotology, Inc.) |
| References: | Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003;56:395–407. Kamudoni P, Johns NP, Salek S. Living with chronic disease: Measuring important patient-reported outcomes. 2018. Ward MM, Marx AS, Barry NN. Identification of clinically important changes in health status using receiver operating characteristic curves. J Clin Epidemiol 2000;53:279–84. Fayers PM, Machin D. Quality of Life: The Assessment, Analysis and Reporting of Patient-Reported Outcomes . The Atrium, Southern Gate, Chichester, West Sussex PO19 8SQ, England: Wiley Blackwell; 2007. Engel L, Beaton DE, Touma Z. Minimal clinically important difference: A review of outcome measure score interpretation. Rheum Dis Clin North Am 2018;44:177–88. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407–15. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61:102–9. Johnston BC, Ebrahim S, Carrasco-Labra A, et al. Minimally important difference estimates and methods: a protocol. BMJ Open 2015;5:e007953. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR; Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371–83. World Health O. Chronic Suppurative Otitis Media: Burden of Illness and Management Options . Geneva: World Health Organization; 2004. Bächinger D, Röösli C, Ditzen B, Huber AM. Development and validation of the Zurich Chronic Middle Ear Inventory (ZCMEI-21): An electronic questionnaire for assessing quality of life in patients with chronic otitis media. Eur Arch Otorhinolaryngol 2016;273:3073–81. Yang R, Zhang Y, Han W, et al. Measuring health-related quality of life in chronic otitis media in a Chinese population: Cultural adaption and validation of the Zurich Chronic Middle Ear Inventory (ZCMEI-21-Chn). Health Qual Life Outcomes 2020;18:218. Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005;8:94–104. Bachinger D, Takagi D, Yamada H, et al. Japanese translation, cross-cultural adaption and multicentre validation of the Zurich Chronic Middle Ear Inventory (ZCMEI-21-Jap). Auris Nasus Larynx 2019;46:18–23. Chatzimichalis M, Epprecht L, Weder S, et al. English translation and validation of the Zurich Chronic Middle Ear Inventory (ZCMEI-21-E) assessing quality of life in chronic otitis media: A prospective international multicentre study. Clin Otolaryngol 2019;44:254–62. doi:10.1111/coa.13275. (PMID: 10.1111/coa.13275) Ralli M, Quaranta N, Canale A, et al. Cross-cultural adaption and validation of the Zurich Chronic Middle Ear Inventory translated into Italian (ZCMEI-21-It)—A prospective multicenter study. Otol Neurotol 2019;40:351–8. Altman DG, Vergouwe Y, Royston P, Moons KGM. Prognosis and prognostic research: Validating a prognostic model. BMJ 2009;338:b605. Japan Otological Society. Guideline for Reporting Hearing Results in Middle Ear and Mastoid Surgery. Available at: https://www.otology.gr.jp/common/pdf/mastoid2010.pdf . Accessed Dec 26, 2019. Li S, Ke J, Yang R, et al. Quality of life assessment after endoscopic and microscopic myringoplasty using Chinese version of the Zurich chronic middle ear inventory. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2021;35:297–301. Cohen J. Chapter 1—The concepts of power analysis. In: Cohen J, ed. Statistical Power Analysis for the Behavioral Sciences . 111 Fifth Avenue, New York, New York 10003: Academic Press; 1977:1–17. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81–7. Committee on Hearing and Equilibrium Guidelines for the Evaluation of Results of Treatment of Conductive Hearing Loss. American Academy of Otolaryngology–Head and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:186–7. Bächinger D, Mlynski R, Weiss NM. Establishing the minimal clinically important difference (MCID) of the Zurich Chronic Middle Ear Inventory (ZCMEI-21) in patients treated for chronic middle ear disease. Eur Arch Otorhinolaryngol 2020;277:1039–44. Basra MK, Salek MS, Camilleri L, Sturkey R, Finlay AY. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): Further data. Dermatology 2015;230:27–33. Tsimpida D, Kontopantelis E, Ashcroft D, Panagioti M. Comparison of self-reported measures of hearing with an objective audiometric measure in adults in the English Longitudinal Study of Ageing. JAMA Netw Open 2020;3:e2015009. Terwee CB, Roorda LD, Dekker J, et al. Mind the MIC: Large variation among populations and methods. J Clin Epidemiol 2010;63:524–34. Quinten C, Kenis C, Decoster L, et al. Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery. Qual Life Res 2019;28:663–76. Hägg O, Fritzell P, Odén A, Nordwall A; Swedish Lumbar Spine Study Group. Simplifying outcome measurement: Evaluation of instruments for measuring outcome after fusion surgery for chronic low back pain. Spine (Phila Pa 1976) 2002;27:1213–22. Weiss NM, Bachinger D, Rrahmani A, et al. Mapping the ChOLE classification to hearing outcomes and disease-specific health-related quality of life. Eur Arch Otorhinolaryngol 2020;277:2729–38. Jotic AD, Opankovic AM, Radin ZZ, et al. Symptoms of depression, anxiety and stress in patients with chronic otitis media. PLoS One 2022;17:e0270793. Collins GS, Ogundimu EO, Altman DG. Sample size considerations for the external validation of a multivariable prognostic model: A resampling study. Stat Med 2016;35:214–26. Revicki DA, Cella D, Hays RD, et al. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 2006;4:70. |
| تواريخ الأحداث: | Date Created: 20240703 Date Completed: 20240712 Latest Revision: 20240716 |
| رمز التحديث: | 20240716 |
| DOI: | 10.1097/MAO.0000000000004237 |
| PMID: | 38956761 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1537-4505 |
|---|---|
| DOI: | 10.1097/MAO.0000000000004237 |